Answer
Oct 01, 2025 - 05:51 AM
HARVONI, a combination of ledipasvir and sofosbuvir, is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults and pediatric patients aged 3 years and older. It is used for HCV genotypes 1, 4, 5, or 6 and can be prescribed with or without ribavirin, depending on the specific patient characteristics and medical history.
